2012

Non-inferiority of miltefosine versus meglumine antimoniate for cutaneous leishmaniasis in children.

Rubiano LC; Miranda MC; Muvdi S; Rodríguez-Barraquer I; Pérez M; Montero LM; Rojas MX; Garcerant D; Prager M; Osorio L; Nicholls RS;  Saravia NG.

2015

Parasitological confirmation and analysis of Leishmania diversity in asymptomatic and subclinical infection following resolution of cutaneous leishmaniasis

Rosales-Chilama; Gongora RE; Valderrama L; Jojoa J; Alexander N; Rubiano LC; Cossio A; Gore Saravia N; Gomez MA

2017

Pathophysiology of Leishmania infection during pregnancy

Berger B; Bartlett AH; Saravia NG; Galindo-Sevilla N.

2017

Pharmacokinetics of miltefosine in children and adults with cutaneous leishmaniasis

Castro MM; Gómez MA; Kip A; Cossio A; Ortíz E; Navas A; Dorlo T; Saravia NG.

2019

Phenotypic and functional stability of leukocytes from human peripheral blood samples: considerations for the design of immunological studies

Navas A; Giraldo-Parra L; Prieto MD; Cabrera J; Gomez MA

2016

Plan for eliminating mother-to-child transmission of syphilis. El plan de eliminación de la transmisión materna-infantil de la sífilis, una oportunidad para iniciar la implementación de la reglamentación de la ley estatutaria de la salud

Gaitán-Duarte H; Cruz-Aconcha A. [Editorial].

2018

Point-Counterpoint: Piperacillin-Tazobactam Should Be Used To Treat Infections with Extended-Spectrum-Beta-Lactamase-Positive Organisms

Schuetz AN; Reyes S; Tamma PD

2014

Population structure among Mycobacterium tuberculosis isolates from pulmonary tuberculosis patients in Colombia.

Realpe T; Correa N; Rozo JC; Ferro BE; Gómez V; Zapata E; Ribon W; Puerto G; Castro G; Nieto LM; Diaz ML; Rivera O; Couvin D; Rastogi N; Arbeláez MP; Robledo J.

2013

Predictive value of molecular drug resistance testing of Mycobacterium tuberculosis isolates in Valle del Cauca, Colombia

Ferro B; García P; Nieto LM; van Soolingen D

2017

Prevalence and factors related to Clostridium difficile infection in a high complexityhospital in Cali, Colombia. [Prevalencia y factores relacionados con la infección por Clostridium difficile en un centro hospitalario de alta complejidad en Cali (Colombia)]

Oñate-Gutiérrez JM; Villegas MV; Correa A.